Table 2.

Measures table

Variables	Instruments	Methods	Analysis	Time
Knowledge and attitude about patient-centered care, SDM, use of DSTs	Pre and post survey of providers Semi-structured interviews	90 min. CME interactive orientation sections with providers and exit interviews	Descriptive pre-post analysis Thematic analysis of transcribed interviews using Dedoose	Pre and post physician education End of study
Medication adherence	Medication Events Monitoring Systems ( eCap). Cronbach’s alpha=.0.85 ARMS Survey	eCap upload to BRIC RA will administer form to patient pre/post intervention to evaluate treatment medication adherence	Linear or generalized linear mixed effects model and Beta regression to evaluate changes over time for groups 1 and 2	Baseline, 6 and 12 months
Patient Activation Measure Scores/Level	Patient Activation Measure (PAM) Cronbach’s alpha=.91	RA administers form to patient pre and post intervention	Linear or generalized linear mixed effects model for change overtime for groups 1 and 2	Baseline, 6 and 12 months
Self-Efficacy Scores	Stanford 6-Item Self Efficacy Scale Summary DM Self-Activities Measure (SDSCA)	RA administers form to patient pre and post intervention to evaluate change in self-efficacy	Linear or generalized linear mixed effects models for change over time for groups 1 and 2	Baseline, 6 and 12 months
Rate of use of aspirin/antiplatelets, beta-blockers, ACEI/ARBs, cholesterol assessment and treatment, DM medications	PAI agreement in chart Patient medication list Patient medical record Texting log	Chart audits to compare the rate of use of aspirin/antiplatelets, beta-blockers, ACEI, cholesterol assessment and treatment of DM	Linear or generalized linear mixed effects model for change overtime for groups 1 and 2	Baseline, 6 and 12 months
Rate of BP control Diabetic Control (HbA1c)	Digital sphygmomanometer , HbA1c assessment in the community lab using standard instrument	Three BP measurements, 1 minute intervals, using appropriate cuff Reliable point-of-care HbA1c test	Linear or generalized linear mixed effects model for change overtime for groups 1 and 2	Average BP and HbA1c at baseline, 6 and 12 months
Combined Outcome Measure for Risk Communication & Treatment Decision Making Effectiveness (COMRADE)	COMRADE questionnaire Cronbach’s alpha=.92 CollaboRate SDM Measure	RA administers form pre/post intervention to evaluate satisfaction with shared decision-making	Linear or generalized linear mixed effects model for change overtime for groups 1 and 2	COMRADE use at baseline, 6 and 12 months
PAI + Texting use rate & acceptability rating by clinical staff	PAI agreement forms; Texting log; pre/post physician/staff surveys; physician/staff interviews	RA records and chart abstraction to determine PAI + Texting use Staff meeting and survey to explore adoption + practice diary entries	Determine rate of use of PAI +Texting Frequencies of responses to evaluation surveys	Chart Abstraction at 6 months. RA tracks rates throughout study